Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001209191-23-032351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-23 | TMCI | MOTT RICHARD W | Dir | A - Grant | $0.00 | +2,753 | 907.8K | +0.3% | $0 |
| D | 2023-05-25 | 2023-05-23 | TMCI | MOTT RICHARD W | Dir | A - Grant | $0.00 | +6,305 | 6,305 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-23 | A | A | 2,753 | $0.00 | 907,753 | D | — | — | (F1) Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. (F3) Includes 2,753 RSUs. (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-23 | A | A | 6,305 | $0.00 | 6,305 | D | $26.34 · — to 2033-05-23 | 6,305 Common Stock | (F4) The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. |